{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:54:51Z","timestamp":1791276891248,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.nbd.2006.07.004","type":"journal-article","created":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T14:43:24Z","timestamp":1157640204000},"page":"286-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Establishing a standardized therapeutic testing protocol for spinal muscular atrophy"],"prefix":"10.1016","volume":"24","author":[{"given":"Li-Kai","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzer-Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2006.07.004_bib1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy","volume":"114","author":"Azzouz","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2006.07.004_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra035354","article-title":"Medical progress: bipolar disorder","volume":"351","author":"Belmaker","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2006.07.004_bib3","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199601183340308","article-title":"Antiepileptic drugs","volume":"334","author":"Brodie","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2006.07.004_bib5","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2006.07.004_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.152.5.1107","article-title":"Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy","volume":"152","author":"Cifuentes-Diaz","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2006.07.004_bib7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Cifuentes-Diaz","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"15","author":"Crawford","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2006.07.004_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(03)02699-4","article-title":"Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats","volume":"975","author":"Cui","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2006.07.004_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmg.26.12.761","article-title":"A Hungarian study on Werdnig\u2013Hoffmann disease","volume":"26","author":"Czeizel","year":"1989","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0041-008X(77)90083-7","article-title":"A simple, sensitive, and objective method for early assessment of acrylamide neuropathy in rats","volume":"40","author":"Edwards","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2006.07.004_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/hmg\/9.5.849","article-title":"Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy","volume":"9","author":"Frugier","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0959-437X(02)00301-5","article-title":"The molecular bases of spinal muscular atrophy","volume":"12","author":"Frugier","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.nbd.2006.07.004_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.10455","article-title":"Riluzole attenuates spinal muscular atrophy disease progression in a mouse model","volume":"28","author":"Haddad","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2006.07.004_bib15","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1523\/JNEUROSCI.5747-03.2004","article-title":"Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis","volume":"24","author":"Hao","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.07.004_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/00207459209003286","article-title":"Correlation of neuronal cell body size in motor cortex and hippocampus with body height, body weight, and axonal length","volume":"65","author":"Ho","year":"1992","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.nbd.2006.07.004_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/9.3.341","article-title":"Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III","volume":"9","author":"Jablonka","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(03)00350-8","article-title":"Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neuron from spontaneous cell death: a role of histone deacetylase inhibition","volume":"542","author":"Jeong","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2006.07.004_bib20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2006.07.004_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/nbdi.1996.0014","article-title":"Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease","volume":"3","author":"Kennel","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2006.07.004_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/neu.1998.15.125","article-title":"A mouse model of graded contusive spinal cord injury","volume":"15","author":"Kuhn","year":"1998","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.nbd.2006.07.004_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/hmg\/ddg143","article-title":"Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy","volume":"12","author":"Lesbordes","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.288.5464.335","article-title":"Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model","volume":"288","author":"Li","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nbd.2006.07.004_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1016123413038","article-title":"Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis","volume":"7","author":"Manabe","year":"2002","journal-title":"Apoptosis"},{"key":"10.1016\/j.nbd.2006.07.004_bib27","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/hmg\/9.16.2451","article-title":"Animal models of spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2004.10.001","article-title":"Histone deacetylase inhibitors","volume":"40","author":"Monneret","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.nbd.2006.07.004_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0960-8966(91)90052-T","article-title":"Workshop report: international SMA collaboration","volume":"1","author":"Munsat","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2006.07.004_bib30","unstructured":"National Institutes of Health, U.S., 2006. Valproic acid and carnitine in patients with spinal muscular atrophy (accessed Jun 28, 2006, at http:\/\/www.clinicaltrials.gov\/ct\/gui\/show\/NCT00227266)."},{"key":"10.1016\/j.nbd.2006.07.004_bib31","doi-asserted-by":"crossref","first-page":"SI\/17","DOI":"10.1007\/BF03161151","article-title":"Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis","volume":"247","author":"Shaw","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2006.07.004_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2006.07.004_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2001-15264","article-title":"Spinal muscular atrophy","volume":"21","author":"Talbot","year":"2001","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.nbd.2006.07.004_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrg1045","article-title":"Modelling brain diseases in mice: the challenges of design and analysis","volume":"4","author":"Watase","year":"2003","journal-title":"Nat. Rev., Genet."},{"key":"10.1016\/j.nbd.2006.07.004_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2006.07.004_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0960-8966(99)00016-4","article-title":"59th ENMC International Workshop: spinal muscular atrophies: recent progress and revised diagnostic criteria. 17\u201319 April 1998, Soestduinen, The Netherlands","volume":"9","author":"Zerres","year":"1999","journal-title":"Neuromuscul. Disord."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:59:44Z","timestamp":1760849984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996106001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0969996106001653"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2006.07.004","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing a standardized therapeutic testing protocol for spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2006.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}